Arraystar
Private Company
Funding information not available
Overview
Arraystar is a specialized service and product provider in the RNA research space, focusing on the complex world of non-coding RNA biology. The company leverages microarray and sequencing technologies to offer comprehensive profiling services for RNA expression, modifications (like m6A and tRNA modifications), and structures (such as R-loops and G-quadruplexes). Its business model is built on providing critical research tools and contract services to academic and institutional researchers, supporting publications in high-impact journals. Arraystar operates as a private, revenue-generating company serving the global life science research market.
Technology Platform
Proprietary microarray and next-generation sequencing platforms for comprehensive profiling of non-coding RNA expression, modifications (e.g., m6A, tRNA modifications), and structures (e.g., R-loops, G-quadruplexes).
Opportunities
Risk Factors
Competitive Landscape
Arraystar competes in a niche segment of the research tools market. It faces competition from large genomics service providers (e.g., Illumina, Azenta), other specialized contract research organizations, and university core facilities. Its differentiation lies in its deep specialization in complex RNA analyses, integrated 'sample-to-data' service model, and established reputation for quality supporting high-impact publications.